F&P Healthcare guidance brings dip

Fisher & Paykel Healthcare disappointed the market in releasing new guidance for full year operating revenue to be in the range of $1.675 billion and $1.70 billion. This was around 4.3% below market expectation and the share price fell $2.20 to $25.70. FPH also advised investors of elevated freight costs, which it estimates will weigh […]